This Wall St Journal article/video on Johnson&Johnson is really interesting...describing how the big pharma company is scouting out deals with small biotech companies.
http://online.wsj.com/news/article_email/SB10001424052702304703804579384871050414310-lMyQjAxMTA0MDAwOTEwNDkyWj
It raises hopes for all small aussie biotechs, but particularly for Biotron.
Why? The article says Hepatitis C is one of the diseases where J&J is actively scouting small biotech companies to find prospective drugs.
Oh yes, and CEO Michelle Miller is ex-J&J, so is Biotron board member Dr Susan Ponds, as is fellow board member Dr Dennis Wade.
Nothing conclusive, of course, but food for thought
GLTAH
- Forums
- ASX - By Stock
- BIT
- johnson & johnson
johnson & johnson
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $5.671K | 298.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 512798 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 1050263 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 512798 | 0.019 |
10 | 1774771 | 0.018 |
8 | 927388 | 0.017 |
12 | 3258350 | 0.016 |
7 | 865000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1000263 | 4 |
0.021 | 555000 | 2 |
0.022 | 997769 | 4 |
0.023 | 1100772 | 2 |
0.024 | 153949 | 2 |
Last trade - 15.59pm 04/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |